Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages
Mingxuan Zhu(Sun Yat-sen University), Yanxin Luo(Sun Yat-sen University), Linping Wu(Chinese Academy of Sciences), Rui Ma(Tsinghua University), Ping Yuan(Anhui Medical University), Huichuan Yu(Sun Yat-sen University), Meijin Huang(Sun Yat-sen University), Liangliang Bai(Sichuan University), Jinxin Lin(Sun Yat-sen University), Xiaolin Wang(Dalian Medical University), Hong Bai(Sun Yat-sen University), Yingjie Li(Peking University), Yumo Xie(Sun Yat-sen University), Xiaoxia Liu(Sun Yat-sen University), Shaoyong Peng(Sun Yat-sen University)
Cited by 55
Related Papers
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2021|304